Carson Wealth (CWM LLC)
MPLT

Carson Wealth (CWM LLC)’s MapLight Therapeutics MPLT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16K Buy
+57
New +$1.02K ﹤0.01% 5376

Other funds holding MPLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Carson Wealth (CWM LLC)'s MPLT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) opened a new position in MapLight Therapeutics (MPLT) in Q1 2026: 57 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #5376 among its holdings.

81 funds tracked by Wall St. Rank hold MPLT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 57 shares of MapLight Therapeutics worth $1.16K as of Q1 2026.
  • MapLight Therapeutics was a new Carson Wealth (CWM LLC) position in Q1 2026.
  • MapLight Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5376 holding.
  • 81 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.